<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id>
<journal-id journal-id-type="publisher-id">CNS</journal-id>
<journal-title-group>
<journal-title>CNS Neuroscience &amp; Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1755-5930</issn>
<issn pub-type="epub">1755-5949</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29388323</article-id>
<article-id pub-id-type="pmc">5969305</article-id>
<article-id pub-id-type="doi">10.1111/cns.12810</article-id>
<article-id pub-id-type="publisher-id">CNS12810</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders</article-title>
<alt-title alt-title-type="left-running-head">TOMAS‐ROIG et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="cns12810-cr-0001">
<name>
<surname>Tomas‐Roig</surname>
<given-names>Jordi</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8997-3436</contrib-id>
<address>
<email>jtomas@idibgi.org</email>
</address>
<xref ref-type="aff" rid="cns12810-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0002">
<name>
<surname>Piscitelli</surname>
<given-names>Fabiana</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0003">
<name>
<surname>Gil</surname>
<given-names>Vanesa</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0004">
<name>
<surname>Quintana</surname>
<given-names>Ester</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0005">
<name>
<surname>Ramió‐Torrentà</surname>
<given-names>Lluís l.</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0006">
<name>
<surname>del Río</surname>
<given-names>Jose Antonio</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0007">
<name>
<surname>Moore</surname>
<given-names>Timothy Patrick</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0008">
<name>
<surname>Agbemenyah</surname>
<given-names>Hope</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0009">
<name>
<surname>Salinas</surname>
<given-names>Gabriela</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0010">
<name>
<surname>Pommerenke</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0011">
<name>
<surname>Lorenzen</surname>
<given-names>Stephan</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0010">
<sup>10</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0012">
<name>
<surname>Beißbarth</surname>
<given-names>Tim</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0013">
<name>
<surname>Hoyer‐Fender</surname>
<given-names>Sigrid</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0012">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0014">
<name>
<surname>Di Marzo</surname>
<given-names>Vincenzo</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12810-cr-0015">
<name>
<surname>Havemann‐Reinecke</surname>
<given-names>Ursula</given-names>
</name>
<xref ref-type="aff" rid="cns12810-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns12810-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cns12810-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry and Psychotherapy</named-content>
<institution>University of Göttingen</institution>
<named-content content-type="city">Göttingen</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0002">
<label><sup>2</sup></label>
<institution>Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)</institution>
<named-content content-type="city">Göttingen</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Girona Neuroimmunology and Multiple Sclerosis Unit (UNIEMTG)</named-content>
<named-content content-type="organisation-division">Dr. Josep Trueta University Hospital and Neurodegeneration and Neuroinflammation Research Group</named-content>
<institution>Girona Biomedical Research Institute (IDIBGI)</institution>
<named-content content-type="city">Girona</named-content>
<country country="ES">Spain</country>
</aff>
<aff id="cns12810-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Endocannabinoid Research Group</named-content>
<named-content content-type="organisation-division">Institute of Biomolecular Chemistry</named-content>
<institution>Consiglio Nazionale delle Ricerche</institution>
<named-content content-type="city">Pozzuoli</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="cns12810-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Institute for Bioengineering of Catalonia (IBEC)</named-content>
<institution>The Barcelona Institute of Science and Technology</institution>
<institution>Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)</institution>
<named-content content-type="city">Barcelona</named-content>
<country country="ES">Spain</country>
</aff>
<aff id="cns12810-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Department of Cell Biology, Physiology and Immunology</named-content>
<named-content content-type="organisation-division">Faculty of Biology</named-content>
<institution>University of Barcelona</institution>
<named-content content-type="city">Barcelona</named-content>
<country country="ES">Spain</country>
</aff>
<aff id="cns12810-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Department of Child and Adolescent Psychiatry</named-content>
<institution>University Hospital Münster</institution>
<named-content content-type="city">Münster</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Laboratory for Aging and Cognitive Diseases</named-content>
<institution>European Neuroscience Institute</institution>
<named-content content-type="city">Goettingen</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0009">
<label><sup>9</sup></label>
<institution>Department of Developmental Biochemistry, Georg‐August‐Universität Göttingen</institution>
<named-content content-type="city">Göttingen</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Department of Medical Statistics</named-content>
<institution>University Medical Center Göttingen</institution>
<named-content content-type="city">Göttingen</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0011">
<label><sup>11</sup></label>
<named-content content-type="organisation-division">Department of Molecular Medicine</named-content>
<institution>Bernhard Nocht Institute for Tropical Medicine</institution>
<named-content content-type="city">Hamburg</named-content>
<country country="DE">Germany</country>
</aff>
<aff id="cns12810-aff-0012">
<label><sup>12</sup></label>
<named-content content-type="organisation-division">Johann‐Friedrich‐Blumenbach Institute for Zoology and Anthropology</named-content>
<institution>Developmental Biology</institution>
<named-content content-type="city">Göttingen</named-content>
<country country="DE">Germany</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Jordi Tomas‐Roig, Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.<break></break>
Email: <email>jtomas@idibgi.org</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2018</year>
</pub-date>
<volume>24</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1111/cns.2018.24.issue-6</issue-id>
<fpage>528</fpage>
<lpage>538</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>CNS Neuroscience &amp; Therapeutics</italic> Published by John Wiley &amp; Sons Ltd.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CNS-24-528.pdf" xlink:type="simple"></self-uri>
<abstract id="cns12810-abs-0001">
<title>Summary</title>
<sec id="cns12810-sec-0001">
<title>Introduction</title>
<p>Vulnerability to psychiatric manifestations is achieved by the influence of genetic and environment including stress and cannabis consumption. Here, we used a psychosocial stress model based on resident‐intruder confrontations to study the brain corticostriatal‐function, since deregulation of corticostriatal circuitries has been reported in many psychiatric disorders. <styled-content style="fixed-case">CB</styled-content>
<sub>1</sub> receptors are widely expressed in the central nervous system and particularly, in both cortex and striatum brain structures.</p>
</sec>
<sec id="cns12810-sec-0002">
<title>Aims and methods</title>
<p>The investigation presented here is addressed to assess the impact of repeated stress following acute cannabinoid exposure on behavior and corticostriatal brain physiology by assessing mice behavior, the concentration of endocannabinoid and endocannabinoid‐like molecules and changes in the transcriptome.</p>
</sec>
<sec id="cns12810-sec-0003">
<title>Results</title>
<p>Stressed animals urinated frequently; showed exacerbated scratching activity, lower striatal <italic>N</italic>‐arachidonylethanolamine (<styled-content style="fixed-case">AEA</styled-content>) levels and higher cortical expression of cholinergic receptor nicotinic alpha 6. The cannabinoid agonist <styled-content style="fixed-case">WIN</styled-content>55212.2 diminished locomotor activity while the inverse agonist increased the distance travelled in the center of the open field. Upon <styled-content style="fixed-case">CB</styled-content>
<sub>1</sub> activation, <italic>N</italic>‐oleoylethanolamide and <italic>N</italic>‐palmitoylethanolamide, two <styled-content style="fixed-case">AEA</styled-content> congeners that do not interact directly with cannabinoid receptors, were enhanced in the striatum. The co‐administration with both cannabinoids induced an up‐regulation of striatal <styled-content style="fixed-case">FK</styled-content>506 binding protein 5. The inverse agonist in controls reversed the effects of <styled-content style="fixed-case">WIN</styled-content>55212.2 on motor activity. When Rimonabant was injected under stress, the cortical levels of 2‐arachidonoylglycerol were maximum. The agonist and the antagonist influenced the cortical expression of cholinergic receptor nicotinic alpha 6 and serotonin transporter neurotransmitter type 4 in opposite directions, while their co‐administration tended to produce a null effect under stress.</p>
</sec>
<sec id="cns12810-sec-0004">
<title>Conclusions</title>
<p>The endocannabinoid system had a direct effect on serotoninergic neurotransmission and glucocorticoid signaling. Cholinergic receptor nicotinic alpha‐6 was shown to be deregulated in response to stress and following synthetic cannabinoid drugs thus could confer vulnerability to cannabis addiction and psychosis. Targeting the receptors of endocannabinoids and endocannabinoid‐like mediators might be a valuable option for treating stress‐related neuropsychiatric symptoms.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cns12810-kwd-0001">
<styled-content style="fixed-case">CB</styled-content>
<sub>1</sub>
</kwd>
<kwd id="cns12810-kwd-0002">Chrna6 and Slc6a4</kwd>
<kwd id="cns12810-kwd-0003">Fkbp5</kwd>
<kwd id="cns12810-kwd-0004">psychosocial stress</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Deutsche Forschungsgemeinschaft</funding-source>
<award-id>CNMPB C1‐6</award-id>
<award-id>TO 977/1‐1</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<page-count count="11"></page-count>
<word-count count="8228"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cns12810</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:02.05.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="cns12810-cit-1001" publication-type="journal">
<string-name>
<surname>Tomas‐Roig</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Piscitelli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gil</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders</article-title>. <source xml:lang="en"/>CNS Neurosci Ther. <year>2018</year>;<volume>24</volume>:<fpage>528</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12810</pub-id>
<pub-id pub-id-type="pmid">29388323</pub-id></mixed-citation>
</p>
<fn-group id="cns12810-ntgp-0001">
<fn id="cns12810-note-1001">
<p>The first and last author share senior authorship.</p>
</fn>
<fn fn-type="equal" id="cns12810-note-1002">
<p>The second and third author contributed equally to this work.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="cns12810-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Vulnerability to psychiatric disorders is determined by the interaction of genetic and environmental factors<xref ref-type="ref" rid="cns12810-bib-0001">1</xref> such as psychosocial stress and cannabis consumption. The dysregulation of corticostriatal circuitries is involved in the pathophysiology of psychotic disorders.<xref ref-type="ref" rid="cns12810-bib-0002">2</xref> Psychosocial stress has a remarkable influence on central nervous system (CNS) and animal behavior.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> When an organism is exposed to a stressor, biological mechanisms such as the hypothalamic‐pituitary‐adrenal axis (HPA) and cardiovascular readjustments come into play to restore homeostasis.<xref ref-type="ref" rid="cns12810-bib-0004">4</xref> Under standard conditions, HPA axis function is mainly influenced by stress, which enhances its activity, and the circadian rhythm.<xref ref-type="ref" rid="cns12810-bib-0005">5</xref> However, when stress is prolonged over the time and the activation exceeds the capacity to keep body's homeostasis, psychopathological sequelae can appear. Among the broad spectrum of brain structures closely involved in anxiety and stress disorders (for review see Ref. <xref ref-type="ref" rid="cns12810-bib-0006">6</xref>), we directed our efforts toward the dorsal striatum (dorsal CPu) and the prefrontal cortex (PFC) due to the fact that these areas are critically involved in social relationships.<xref ref-type="ref" rid="cns12810-bib-0007">7</xref>, <xref ref-type="ref" rid="cns12810-bib-0008">8</xref> There is a growing body of the literature that suggests that glucocorticoid receptor(s) involve G protein‐dependent mechanisms.<xref ref-type="ref" rid="cns12810-bib-0009">9</xref> In particular, corticostriatal activity is modulated by a variety of G protein‐coupled receptors such as the cannabinoid CB<sub>1</sub> receptor, which is highly abundant in the CNS.<xref ref-type="ref" rid="cns12810-bib-0010">10</xref> CB<sub>1</sub> receptors are the main target for endogenous endocannabinoids lipid signaling molecules and mediate both Δ<sup>9</sup>‐tetrahydrocannabinol (<italic>THC</italic>) and synthetic cannabinoid drugs pharmacological actions.<xref ref-type="ref" rid="cns12810-bib-0011">11</xref> The main endocannabinoids molecules for CB<sub>1</sub> receptors are <italic>N</italic>‐arachidonylethanolamine (AEA)<xref ref-type="ref" rid="cns12810-bib-0012">12</xref> and 2‐arachidonoylglycerol (2‐AG).<xref ref-type="ref" rid="cns12810-bib-0013">13</xref>
<italic>N</italic>‐arachidonoylphospatidylethanolamine‐specific phospholipase D (NAPE‐PLD) is responsible for the production of AEA, while 2‐AG is mostly synthesized by diacylglycerol lipase (DAGL‐α) in the CNS.<xref ref-type="ref" rid="cns12810-bib-0014">14</xref> After activating cannabinoid receptors, the endocannabinoid AEA and related endocannabinoid‐like NAEs PEA and OEA are enzymatically hydrolyzed by the fatty acid amide hydrolase (FAAH) while 2‐AG is primarily metabolized by monoacylglycerol lipase (MAGL).<xref ref-type="ref" rid="cns12810-bib-0015">15</xref>
</p>
<p>Interestingly, the endocannabinoid system has been described to have a direct effect on both neurotransmission<xref ref-type="ref" rid="cns12810-bib-0016">16</xref> and glucocorticoid signaling.<xref ref-type="ref" rid="cns12810-bib-0017">17</xref> Despite the lack of knowledge concerning the concrete corticostriatal mechanisms underlying anxiety, both pharmacologic (synthetic cannabinoid drugs) and behavioral testing have been applied. Thus, the aim of this study was to investigate the interplay between repeated long‐term exposure to psychosocial stress and acute challenge with cannabinoid drugs on mice corticostriatal circuitries. For this purpose, we evaluated the animals by behavioral testing and then quantified endocannabinoid and endocannabinoid‐like molecules and also changes in whole‐genome gene expression profile.</p>
</sec>
<sec id="cns12810-sec-0006">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<p>All animal experimental procedures were approved by University of Göttingen Institutional Animal Care and Use Committee and also were in accordance with NIH guidelines for the use of animals in research and the European Communities Council Directive (86/609/EEC).</p>
<sec id="cns12810-sec-0007">
<label>2.1</label>
<title>Animals</title>
<p>A total of 120 C57Bl6/J male mice aged 7‐8 weeks were purchased from Charles River Laboratories (Sulzfeld, Germany). On arrival, they were kept five per cage and maintained under standard conditions (12‐hour light/dark cycle with 6:00/18:00 lights on/off, a room temperature of 21 ± 2°C, and food and water ad libitum). After one‐week habituation period, mice were subjected to the experiment. One‐year‐old FVB/N male mice (Charles River Laboratories, Sulzfeld, Germany) were kept individually and used as residents. FVB/N mice were selected as residents because they are more offensive than the C57Bl/6 strain.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> The FVB/N strain was kept under the same protocol conditions as the C57Bl/6J colony but housed in a separate room to prevent the C57Bl/6J mice habituation to the odor of the residents.</p>
</sec>
<sec id="cns12810-sec-0008">
<label>2.2</label>
<title>Drugs</title>
<p>The CB<sub>1</sub>/CB<sub>2</sub> receptor agonist WIN55212.2 (Sigma‐Aldrich, Seelze, Germany) and the selective cannabinoid CB<sub>1</sub> receptor antagonist Rimonabant (Sequoia Research Products Ltd, Pangbourne, UK) were dissolved in a vehicle solution consisting of 10% DMSO (Sigma‐Aldrich, Seelze, Germany) and 0.1% Tween 80 (Sigma‐Aldrich, Seelze, Germany) in 0.9% saline and prepared on the 21 days of the experiment. A volume of 200 μL of drug and/or vehicle was administered intraperitoneally (WIN55212.2 and Rimonabant were administered at a concentration of 3 mg/kg) before the behavioral testing.</p>
</sec>
<sec id="cns12810-sec-0009">
<label>2.3</label>
<title>Experiment design and experimental groups</title>
<p>The C57Bl6/J male mice were sorted into two groups: Those exposed daily to psychosocial stress for 1 hour (stress) and those who were left undisturbed (control). The stress protocol was performed daily for 3 weeks. On day 21, the animals received an appropriate drug or vehicle injection and then evaluated by behavioral testing. Indeed, control and stressed mice were split into four subgroups each (15 animals per subgroup): mice treated twice with vehicle (Veh), mice subjected first to vehicle and then WIN55212.2 (WIN), mice treated first with Rimonabant and then with WIN55212.2 (Rim+WIN), and mice injected first with Rimonabant and then vehicle (Rim). Following the last injection with either vehicle or cannabinoid drug, the animals were tested by different behavioral paradigms during the rodent active phase (ie, after 8 <sc>pm</sc>).</p>
</sec>
<sec id="cns12810-sec-0010">
<label>2.4</label>
<title>Social stress procedure</title>
<p>An intruder (C57Bl/6J mouse) was placed in the home cage of a resident (FVB/N mouse), and then they freely interacted until the first aggression was achieved. After the first attack, the C57Bl/6J mouse was isolated by the use of a small plastic wire‐mesh cage within the FVB/N mouse's cage protecting the intruder against direct aggression; however, olfactory, visual, and some vibrissae contact with residents were maintained. After 1 hour, the C57Bl/6J mouse was placed again in its home cage. To prevent habituation, every day intruder mice had encounters with different residents. The psychosocial stress protocol was performed once per day at a similar time (after 8 <sc>pm</sc>) to enhance the stress prediction factor in intruders. In contrast, controls were left undisturbed in an empty cage every day for 1 hour. Therefore, controls were subjected to the same experimental protocol in terms of handling and exposure to a new environment (different cage), but they did not interact with the residents.</p>
</sec>
<sec id="cns12810-sec-0011">
<label>2.5</label>
<title>Behavioral assessment</title>
<p>Mice were exposed to psychosocial stress or left undisturbed for 21 days. On day 21, they were acutely treated with different cannabinoid drugs or vehicle and finally evaluated by behavioral testing. The stress paradigm, the administration of drugs, and the behavioral assessment took place during the dark phase (active phase). We directed the behavioral analyses by measuring locomotor and anxiety‐like behavior in the open‐field (OF) test and testing also CNS activity and excitability by use of the functional observational battery (FOB).</p>
<sec id="cns12810-sec-0012">
<label>2.5.1</label>
<title>Functional observational battery</title>
<p>The FOB has been widely used and adapted for general behavioral studies in mice.<xref ref-type="ref" rid="cns12810-bib-0018">18</xref> In this study, the FOB test comprised 28 parameters by which the investigator evaluated CNS activity and excitability by recording neuromuscular and autonomic effects, and sensorimotor reactivity. There were four consecutive testing situations: (i) in the home cage, (ii) in the observer's hand, (iii) in the OF, and (iv) manipulation tests. After a brief assessment in its home cage, each mouse was removed and handled by the observer to evaluate ease‐of‐removal, handling reactivity, and general appearance. Then, each mouse was assessed in an OF arena (60 cm × 90 cm) while the observer analyzed CNS activity, autonomic effects, muscle tone, equilibrium, and sensorimotor reactivity. Gait condition was scored from 1 to 8. The gait was scored as follows: normal gait, ataxia, splayed hind limbs, feet markedly splayed outward from the body, fore‐limb drag, walking on tiptoes, hunched body, and body drag. The severity of gait abnormality was also evaluated on a scale from 1 (normal) to 4 (severely abnormal).<xref ref-type="ref" rid="cns12810-bib-0018">18</xref>
</p>
</sec>
<sec id="cns12810-sec-0013">
<label>2.5.2</label>
<title>Open‐field activity</title>
<p>In the OF test, we evaluated the spontaneous locomotor and exploratory activity of mice. The experiment was conducted in a Plexiglass arena (45 × 45 × 55 cm), and each mouse was left in the same starting position. Animals were allowed to examine the OF for 10 minutes without habituation. We registered the total distance travelled, percent of time moving, time spent in the center (defined as 70% of area), hyperactivity (forward movement with speed greater than 20 cm/s), and the number of rearings by use of the ActiMot software (TSE, Bad Homburg, Germany) as described.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> The apparatus was cleaned with 70% ethanol p.a. between each test.</p>
</sec>
</sec>
<sec id="cns12810-sec-0014">
<label>2.6</label>
<title>Brain sample collection and tissue evaluation</title>
<p>Animals were sacrificed immediately after OF task finished, and brain tissue was collected accordingly. All mice were deeply anesthetized by intraperitoneal injection of 2,2,2‐tribromoethanol (Sigma‐Aldrich, Hamburg, Germany) and then transcardially perfused with cold 0.1% phosphate buffer saline (PBS). Finally, the PFC and the dorsal CPu were freshly isolated and frozen in liquid nitrogen for LC‐MS, RNA seq, and quantitative RT‐PCR.</p>
<sec id="cns12810-sec-0015">
<label>2.6.1</label>
<title>Extraction and measurement of AEA, 2‐AG, OEA, and PEA levels</title>
<p>The endogenous lipid signaling molecules AEA and 2‐AG, and endocannabinoid‐related molecules <italic>N</italic>‐palmitoylethanolamide (PEA), and <italic>N</italic>‐oleoylethanolamide (OEA) were purified from the PFC and the dorsal CPu and then quantified as described elsewhere.<xref ref-type="ref" rid="cns12810-bib-0019">19</xref> First, samples were dounce‐homogenized following with chloroform/methanol/Tris‐HCl 50 mmol/L pH 7.5 (2:1:1, v/v) containing internal deuterated controls solution for AEA, 2‐AG, PEA, and OEA measurement by isotope dilution ([2H]8AEA, [2H]52AG, [2H]4 PEA, [2H]4 OEA (Cayman Chemicals, MI, USA). The lipid organic phase was dried down, weighed, and prepurified on silica gel. Fractions were collected by eluting the column with 99:1, 90:10, and 50:50 (v/v) chloroform/methanol. The 90:10 fraction contained AEA, 2‐AG, PEA, and OEA, and it was used for isotopic dilution liquid chromatography‐atmospheric pressure chemical ionization‐mass spectrometry quantification (LC‐APCI‐MS), as previously described and using selected ion monitoring at M + 1 values for the four compounds and their deuterated homologues, as described in Ref. <xref ref-type="ref" rid="cns12810-bib-0020">20</xref> N = 4 mice/group.</p>
</sec>
<sec id="cns12810-sec-0016">
<label>2.6.2</label>
<title>RNA extraction</title>
<p>Total RNA was extracted from 80 samples (control and stress; Veh, WIN, Rim+WIN, and Rim; PFC and dorsal CPu; N = 5 mice/group) using the TRIzol reagent according to the manufacturer's instructions (Invitrogen, NY, USA). The RNA was digested with RNase‐free DNase (Qiagen, Düsseldorf, Germany) and checked for integrity using capillary gel electrophoresis (Bioanalyzer, Agilent Technologies, Santa Clara, USA).</p>
</sec>
<sec id="cns12810-sec-0017">
<label>2.6.3</label>
<title>cDNA Library Preparation and RNA Seq</title>
<p>The library was prepared using the TruSeq RNA Sample Preparation Kit (Illumina, San Diego, USA) starting from 500 ng of total RNA. The cDNA libraries were quantified using the QuantiFluor dsDNA System (Promega, Madison, USA). The size range of the final cDNA libraries was determined by the Bioanalyzer 2100 (Agilent, Santa Clara, USA). The cDNA libraries were amplified and sequenced using cBot and HiSeq2000 (Illumina, San Diego, USA).</p>
<p>The sequence images were converted with the Illumina BaseCaller software to bcl files, which were demultiplexed to FASTQ files with CASAVA version 1.8.2. Quality was checked via FastQC (version 0.10.0, Babraham Bioinformatics).</p>
</sec>
<sec id="cns12810-sec-0018">
<label>2.6.4</label>
<title>Gene expression analyses</title>
<p>Sequences were aligned to the RefSeq<xref ref-type="ref" rid="cns12810-bib-0021">21</xref> mouse transcriptome using bwa,<xref ref-type="ref" rid="cns12810-bib-0022">22</xref> and raw “hits” per transcript were merged genewise. DESeq was used to analyze the counts per gene.<xref ref-type="ref" rid="cns12810-bib-0023">23</xref> The resulting <italic>P</italic>‐values were corrected using Benjamini‐Hochberg adjustment.<xref ref-type="ref" rid="cns12810-bib-0024">24</xref>
</p>
</sec>
<sec id="cns12810-sec-0019">
<label>2.6.5</label>
<title>Quantitative RT‐PCR</title>
<p>The most relevant top hits deregulated by stress and cannabinoid drugs were further evaluated by quantitative RT‐PCR. First‐strand cDNA was synthesized from 1 μg of total RNA using the High Capacity RNA‐to‐cDNA Kit (Applied Biosystems, Darmstadt, Germany). mRNA expression was quantified by RT‐PCR using the CXF96TM Real‐time PCR system (Bio‐Rad, Hercules, USA). We used GAPDH mRNA as an endogenous control. TaqMan assays for mouse <italic>Chrna6</italic>,<italic> Slc6a4,</italic> and <italic>Fkbp5</italic> cDNAs were selected from validated and predesigned Assays‐on‐Demand (Applied Biosystems, Darmstadt, Germany) and used in real‐time PCR amplifications to detect the expressions of <italic>Chrna6</italic>,<italic> Slc6a4,</italic> and <italic>Fkbp5</italic>. The reactions were performed in triplicate using 2 μL of cDNA in a 10 μL reaction volume. mRNA expression was determined using the comparative cycle threshold (Ct) method with 2<sup>−ΔΔCt</sup>, according to the manufacturer's instructions (Applied Biosystems, Darmstadt, Germany). cDNAs were measured relative to a “calibrator” control sample. The 2<sup>−ΔΔCt</sup> for this “calibrator” was arbitrarily set to 1.</p>
</sec>
</sec>
<sec id="cns12810-sec-0020">
<label>2.7</label>
<title>Statistical analysis</title>
<p>A two‐way ANOVA was used to examine the effects of stress and pharmacological treatment on our cohort of animals. The mean differences among the levels of one factor were determined by one‐way ANOVA or Brown‐Forsythe test when applicable. Bonferroni or nonparametric Tamhane post hoc test was applied for pairwise comparisons. Analysis of simple main effects was performed whether there was a significant interaction of the two main factors. Individual comparisons were made using the Student's <italic>t</italic> test. ANOVA for repeated measures was used to test the equality of means for mice body weight. Significance level was set to <italic>P</italic> &lt; 0.05. Data are represented as mean ± SEM. Significant effects were identified by SPSS (IBM Corp, Chicago, USA).</p>
</sec>
</sec>
<sec id="cns12810-sec-0021">
<label>3</label>
<title>RESULTS</title>
<p>Results are summarized in three main categories: (i) effects of stress, (ii) effects of drugs, and (iii) effects of stress under drug influence.</p>
<sec id="cns12810-sec-0022">
<label>3.1</label>
<title>Effects of stress</title>
<p>We revealed a significant effect of psychosocial stress on body weight throughout the experimental period (<italic>F</italic>(1, 123) = 4.84, <italic>P</italic> &lt; 0.05). Indeed, exposure to 2‐week social defeat paradigm significantly diminished body weight (<italic>t</italic>(122) = 2.78, <italic>P</italic> &lt; 0.01), which returned to control levels by the end of the stress period (Figure <xref ref-type="fig" rid="cns12810-fig-0001">1</xref>, panel A). Social defeat animals displayed a pronounced scratching activity (<italic>F</italic>(1, 123) = 4.06, <italic>P</italic> &lt; 0.05) (Figure <xref ref-type="fig" rid="cns12810-fig-0001">1</xref>, panel B), urinated more frequently (<italic>F</italic>(1, 123) = 4.97, <italic>P</italic> &lt; 0.05) (Figure <xref ref-type="fig" rid="cns12810-fig-0001">1</xref>, panel C), and showed lower levels of AEA (<italic>F</italic>(1, 18) = 36.81, <italic>P</italic> &lt; 0.01, in the dorsal CPu) (Figure <xref ref-type="fig" rid="cns12810-fig-0001">1</xref>, panel D). Transcriptome analysis of the selected brain structures revealed 62 top hits as deregulated genes by chronic psychosocial stress before Benjamini‐Hochberg adjustment (Figure <xref ref-type="supplementary-material" rid="cns12810-sup-0001">S1</xref>). The cholinergic receptor nicotinic alpha 6 (<italic>Chrna6</italic>), as a candidate gene, was further analyzed by quantitative RT‐PCR. Thus, we determined that long‐term exposure to stress increased the expression of <italic>Chrna6</italic> gene (<italic>F</italic>(1, 43) = 38.32, <italic>P</italic> &lt; 0.01, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0001">1</xref>, panel E) when compared to the nonstressed group.</p>
<fig fig-type="Figure" id="cns12810-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Effects of repeated exposure to psychosocial stress. Data are expressed as mean ± <styled-content style="fixed-case">SEM</styled-content>. Exposure to 2‐wk social defeat paradigm significantly diminished body weight (<italic>P</italic> &lt; 0.01), which returned to control levels by the end of the stress period (panel A). Social defeat animals displayed a pronounced scratching activity (<italic>P</italic> &lt; 0.05) (panel B), urinated more frequently (<italic>P</italic> &lt; 0.05) (panel C), and showed lower levels of <styled-content style="fixed-case">AEA</styled-content> content (<italic>P</italic> &lt; 0.01, in the dorsal <styled-content style="fixed-case">CP</styled-content>u) (panel D). We determined that long‐term exposure to stress increased the expression of Chrna6 gene (<italic>P</italic> &lt; 0.01, in the <styled-content style="fixed-case">PFC</styled-content>) (panel E) when compared to controls. An * indicates significant differences between stress group and their respective control group. One or two symbols indicate <italic>P</italic> &lt; 0.05; <italic>P</italic> &lt; 0.01, respectively. N = 15 for behavioral testing, n = 4 for endocannabinoids quantification; n = 5 for whole‐genome gene expression. <styled-content style="fixed-case">PFC</styled-content>, prefrontal cortex; dorsal <styled-content style="fixed-case">CP</styled-content>u, dorsal striatum; <styled-content style="fixed-case">CTR</styled-content>, control; <styled-content style="fixed-case">STS</styled-content>, stress; <styled-content style="fixed-case">AEA</styled-content>,<italic> N</italic>‐arachidonylethanolamine</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="CNS-24-528-g001"></graphic>
</fig>
</sec>
<sec id="cns12810-sec-0023">
<label>3.2</label>
<title>Effects of drugs</title>
<p>Two‐way ANOVA showed a significant main effect of the drug treatment on total distance traveled (<italic>F</italic>(3, 121) = 8.36, <italic>P</italic> &lt; 0.001), distance traveled in center (<italic>F</italic>(3, 121 = 3.72, <italic>P</italic> &lt; 0.05), rearing activity (<italic>F</italic>(3, 121) = 3.07, <italic>P</italic> &lt; 0.05), PEA levels (<italic>F</italic>(3, 17) = 7.72, <italic>P</italic> &lt; 0.01, in the dorsal CPu), and OEA levels (<italic>F</italic>(3, 22) = 5.29, <italic>P</italic> &lt; 0.01, in the dorsal CPu). Drug administration had a remarkable effect on the relative fold change expression for <italic>Fkbp5</italic> (<italic>F</italic>(3, 44) = 11.44, <italic>P</italic> &lt; 0.001, in the dorsal CPu). The main effects of drug treatment were further evaluated by one‐way ANOVA or Brown‐Forsythe test when applicable followed by multiple comparisons post hoc tests (Table <xref ref-type="supplementary-material" rid="cns12810-sup-0003">S1</xref>). In the OF, the cannabinoid agonist WIN decreased the total distance traveled (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel A) while the administration of the inverse agonist Rim significantly antagonized such effects (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel A). Coadministration with both cannabinoid drugs clearly reduced the total distance traveled in comparison with those animals only treated with Rim (<italic>P</italic> &lt; 0.05) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel A). The distance traveled in center, a measure of anxiety‐like behavior, was statistically elevated in animals treated with Rim alone relative to mice only treated with the agonist (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel B). Animals were also observed in their homecage by registering the vertical movements (rearings). We found that animals treated simultaneously with both drugs showed more frequent rearing behavior than WIN‐treated animals (<italic>P</italic> &lt; 0.05) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel C). The quantification of the endocannabinoid‐like molecules, PEA and OEA, revealed the highest amounts for these lipids in mice subjected to acute administration with the agonist (<italic>P</italic> &lt; 0.05, in the dorsal CPu) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel D &amp; E). Genomewide transcriptional profiling revealed two top hits as deregulated genes by WIN and 32 top hits as deregulated genes by Rim before Benjamini‐Hochberg adjustment (Figure <xref ref-type="supplementary-material" rid="cns12810-sup-0001">S1</xref>). The candidate gene (<italic>Fkbp5</italic>) was validated by quantitative RT‐PCR, and main results are depicted in Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref> (panel F). We measured higher transcription rate for <italic>Fkbp5</italic> after administration with Rim+WIN than vehicle (<italic>P</italic> &lt; 0.01, in the dorsal CPu) or when compared to either WIN or Rim alone (<italic>P</italic> &lt; 0.05, <italic>P</italic> &lt; 0.01; respectively, in the dorsal CPu) (Figure <xref ref-type="fig" rid="cns12810-fig-0002">2</xref>, panel F).</p>
<fig fig-type="Figure" id="cns12810-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Effects of cannabinoid drugs administration. Data are expressed as mean ± <styled-content style="fixed-case">SEM</styled-content>. In the <styled-content style="fixed-case">OF</styled-content>, the cannabinoid agonist <styled-content style="fixed-case">WIN</styled-content> decreased t and the total distance traveled (<italic>P</italic> &lt; 0.01) (panel A) while the administration of the inverse agonist Rim significantly antagonized such effects (<italic>P</italic> &lt; 0.01) (panel A). Coadministration with both cannabinoid drugs clearly reduced the total distance traveled in comparison to those animals single treated with Rim (<italic>P</italic> &lt; 0.05) (panel A). The distance traveled in center was statistically higher in animals treated with Rim alone than those mice single treated with the agonist (<italic>P</italic> &lt; 0.01) (panel B). We reported that animals treated simultaneously with both drugs showed more frequent rearing activity in their homecage than those animals treated with <styled-content style="fixed-case">WIN</styled-content> alone (<italic>P</italic> &lt; 0.05) (panel C). We found bigger amount of <styled-content style="fixed-case">PEA</styled-content> and <styled-content style="fixed-case">OEA</styled-content> in mice subjected to single administration with the agonist in comparison with the remaining drug‐treated groups (<italic>P</italic> &lt; 0.05, in the dorsal <styled-content style="fixed-case">CP</styled-content>u) (panel D &amp; E). We measured higher transcription rate for <italic>Fkbp5</italic> gene following administration with Rim+<styled-content style="fixed-case">WIN</styled-content> than the vehicle group (<italic>P</italic> &lt; 0.01, in the dorsal <styled-content style="fixed-case">CP</styled-content>u) or when compared to either <styled-content style="fixed-case">WIN</styled-content> or Rim alone (<italic>P</italic> &lt; 0.05, <italic>P</italic> &lt; 0.01; respectively, in the dorsal <styled-content style="fixed-case">CP</styled-content>u) (panel F). An * indicates significant differences between drug‐treated mice and their respective vehicle group. Comparisons between <styled-content style="fixed-case">WIN</styled-content>‐treated mice and remaining drug treatments are indicated by an §. Otherwise underlined + indicated other significant comparison intragroup. One or two symbols indicate <italic>P</italic> &lt; 0.05; <italic>P</italic> &lt; 0.01, respectively. N = 15 for behavioral testing, n = 4 for endocannabinoids quantification; n = 5 for whole‐genome gene expression. <styled-content style="fixed-case">PFC</styled-content>, prefrontal cortex; dorsal <styled-content style="fixed-case">CP</styled-content>u, dorsal striatum; <styled-content style="fixed-case">OF</styled-content>, open field</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="CNS-24-528-g002"></graphic>
</fig>
</sec>
<sec id="cns12810-sec-0024">
<label>3.3</label>
<title>Effects of stress under drug influence</title>
<p>A 2‐way ANOVA reported a significant interaction between the factors (stress × drug) on total distance traveled in the OF arena (<italic>F</italic>(3, 121) = 2.76, <italic>P</italic> &lt; 0.05), 2‐AG content (<italic>F</italic>(3, 23) = 18.91, <italic>P</italic> &lt; 0.001, in the PFC), and fold change expression for <italic>Chrna6</italic> (<italic>F</italic>(3, 43) = 7.38, <italic>P</italic> &lt; 0.001, in the PFC) and <italic>Slc6a4</italic> gene (<italic>F</italic>(3, 43) = 3.18, <italic>P</italic> &lt; 0.05, in the PFC). Simple main effects of the interaction between the factors are depicted in Table <xref ref-type="supplementary-material" rid="cns12810-sup-0004">S2</xref>.</p>
<p>In an OF arena, repeated long‐term exposure to psychosocial stress exacerbated general motor activity following vehicle administration (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel A). Indeed, social defeat animals exposed to vehicle traveled longer distances than their controls (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel A). However, the pharmacological treatment with WIN reduced the total distance traveled in the OF when compared to Rim‐treated animals under either control or stress conditions (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel A). Likewise, psychosocially stressed mice exposed to the CB<sub>1</sub> agonist WIN alone traveled smaller distances than the vehicle group (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel A). The administration of the inverse agonist in controls enhanced the total distance traveled when compared to vehicle‐exposed animals (<italic>P</italic> &lt; 0.05) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel A). Upon long‐lasting effects of stress, coadministration with Rim+WIN reduced the total distance traveled in comparison with vehicle (<italic>P</italic> &lt; 0.01) and Rim‐treated animals (<italic>P</italic> &lt; 0.01) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel A).</p>
<fig fig-type="Figure" id="cns12810-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Effects of repeated exposure to psychosocial stress following acute cannabinoid drugs administration. Data are expressed as mean ± <styled-content style="fixed-case">SEM</styled-content>. (1) <italic>Effects on mice behavior:</italic> In an open‐field arena, exposure to psychosocial stress exacerbated general motor activity following vehicle administration (panel A‐B). However, psychosocially stressed mice exposed to the agonist <styled-content style="fixed-case">WIN</styled-content> alone traveled smaller distances than the vehicle group (<italic>P</italic> &lt; 0.01) (panel A). The administration of inverse agonist Rim in controls enhanced the total distance traveled when compared to vehicle (<italic>P</italic> &lt; 0.05) (panel A). (2) <italic>Effects on endocannabinoids levels:</italic> Controls treated with Rim alone underwent an increase in 2‐<styled-content style="fixed-case">AG</styled-content> levels when compared to either vehicle or Rim+<styled-content style="fixed-case">WIN</styled-content>‐treated mice (<italic>P</italic> &lt; 0.05, in the <styled-content style="fixed-case">PFC</styled-content>) (panel B). The administration of the inverse agonist Rim by the end of stress period reduced the levels of the endocannabinoid 2‐<styled-content style="fixed-case">AG</styled-content> when compared to controls that received the same drug treatment (<italic>P</italic> &lt; 0.01, in the <styled-content style="fixed-case">PFC</styled-content>) (panel B). (3) <italic>Effects on gene expression:</italic> The use of synthetic cannabinoid drugs decreased the expression of <italic>Chrna6</italic> in controls (<italic>P</italic> &lt; 0.05, in the <styled-content style="fixed-case">PFC</styled-content>) (panel C) and also did but not significantly when <styled-content style="fixed-case">WIN</styled-content> was administered upon stress exposure while the inverse agonist Rim clearly antagonized such effects (<italic>P</italic> &lt; 0.01, in the <styled-content style="fixed-case">PFC</styled-content>) (panel C). Social defeat animals cotreated with Rim+<styled-content style="fixed-case">WIN</styled-content> or treated with Rim alone underwent a remarkable upregulation of <italic>Chrna6</italic> expression when compared to their nonstressed counterparts (<italic>P</italic> &lt; 0.01, in the <styled-content style="fixed-case">PFC</styled-content>) (panel C). We assessed a higher transcription rate for <italic>Slc6a4</italic> gene in controls upon injection with the inverse agonist in comparison with the remaining control groups (<italic>P</italic> &lt; 0.01, in the <styled-content style="fixed-case">PFC</styled-content>) and also when this drug was administered in stressed animals (<italic>P</italic> &lt; 0.01, in the <styled-content style="fixed-case">PFC</styled-content>) (panel D). The remaining comparisons are depicted in the graph. An * indicates significant differences between stress groups and their respective control group. Control or stress intragroup comparisons between vehicle and treated mice are indicated by an §. Otherwise underlined + indicated intragroup comparisons between treatment groups in control or stress conditions. One or two symbols indicate <italic>P</italic> &lt; 0.05; <italic>P</italic> &lt; 0.01, respectively. N = 15 for behavioral testing, n = 4 for endocannabinoids quantification; n = 5 for whole‐genome gene expression. <styled-content style="fixed-case">PFC</styled-content>, prefrontal cortex; <styled-content style="fixed-case">CTR</styled-content>, control; <styled-content style="fixed-case">STS</styled-content>, stress</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="CNS-24-528-g003"></graphic>
</fig>
<p>On the other hand, controls only treated with Rim exhibited higher 2‐AG levels than either vehicle or Rim+WIN‐treated mice (<italic>P</italic> &lt; 0.05, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel B). However, social defeat mice treated with Rim+WIN displayed higher amounts of 2‐AG than their nonstressed counterparts (<italic>P</italic> &lt; 0.01, in the PFC) but also when compared to either vehicle, WIN, or Rim alone under stress (<italic>P</italic> &lt; 0.01, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel B). The administration of the inverse agonist Rim by the end of the stress period reduced the levels of 2‐AG when compared to controls treated with the same drug (<italic>P</italic> &lt; 0.01, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel B).</p>
<p>Whole‐genome gene expression revealed 10 top hits genes deregulated simultaneously by stress and cannabinoid administration before Benjamini‐Hochberg adjustment (Figure <xref ref-type="supplementary-material" rid="cns12810-sup-0001">S1</xref>) (Table <xref ref-type="table" rid="cns12810-tbl-0001">1</xref>). Three of them (<italic>Fkbp5</italic>,<italic> Chrna6,</italic> and <italic>Slc6a4</italic>) were further analyzed by quantitative RT‐PCR. Two‐way ANOVA showed a significant effect of the interaction on <italic>Slc6a4</italic> (<italic>F</italic>(3, 43) = 3.18, <italic>P</italic> &lt; 0.05) and <italic>Chrna6</italic> (<italic>F</italic>(3, 43) = 7.38, <italic>P</italic> &lt; 0.001) in the PFC but did not reveal differences in the dorsal CPu. The use of synthetic cannabinoid drugs diminished the expression of <italic>Chrna6</italic> in controls (<italic>P</italic> &lt; 0.05, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel C) and also did so, but not significantly, when WIN was administered in stressed animals. In contrast, the inverse agonist Rim clearly antagonized the effects of WIN on <italic>Chrna6</italic> expression under stress (<italic>P</italic> &lt; 0.01, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel C). Furthermore, Rim+WIN administration in stressed mice slightly decreased the expression of <italic>Chrna6</italic> when compared to Rim alone, although <italic>Chrna6</italic> expression was higher than with single WIN treatment (<italic>P</italic> &lt; 0.05, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel C). By the end of the stress protocol, acute injection with Rim increased the expression of <italic>Chrna6</italic> in contrast to vehicle (<italic>P</italic> &lt; 0.01, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel C). Social defeat animals exposed to either Rim+WIN or Rim alone underwent an upregulation of <italic>Chrna6</italic> expression when compared to their nonstressed counterparts (<italic>P</italic> &lt; 0.01, in the PFC) (Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel C). It was generally observed that in the PFC, the expression of Slc6a4 transcripts was higher in the control group treated with the inverse agonist Rim compared to all the groups (<italic>P</italic> &lt; 0.01, in the PFC, Figure <xref ref-type="fig" rid="cns12810-fig-0003">3</xref>, panel D).</p>
<table-wrap id="cns12810-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Differentially deregulated top 10 genes in response to chronic psychosocial stress and acute cannabinoid treatment</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Genes</th>
<th align="left" colspan="1" rowspan="1" valign="top">PFC</th>
<th align="left" colspan="1" rowspan="1" valign="top">DS</th>
<th align="left" colspan="1" rowspan="1" valign="top">FC Stress</th>
<th align="left" colspan="1" rowspan="1" valign="top">FC Rim</th>
<th align="left" colspan="1" rowspan="1" valign="top">FC WIN</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<italic>q</italic> value Stress</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<italic>q</italic> value Rim</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<italic>q</italic> value WIN</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Chrna6</bold>
</td>
<td align="left" colspan="1" rowspan="1">33.8</td>
<td align="left" colspan="1" rowspan="1">45.6</td>
<td align="left" colspan="1" rowspan="1">13.5</td>
<td align="left" colspan="1" rowspan="1">−13.2</td>
<td align="left" colspan="1" rowspan="1">−15.2</td>
<td align="left" colspan="1" rowspan="1">6.46E‐11</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Slc6a4</bold>
</td>
<td align="left" colspan="1" rowspan="1">64.2</td>
<td align="left" colspan="1" rowspan="1">102.3</td>
<td align="left" colspan="1" rowspan="1">31.7</td>
<td align="left" colspan="1" rowspan="1">−34.1</td>
<td align="left" colspan="1" rowspan="1">−32.5</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ldlr</td>
<td align="left" colspan="1" rowspan="1">7.5</td>
<td align="left" colspan="1" rowspan="1">7.7</td>
<td align="left" colspan="1" rowspan="1">−0.2</td>
<td align="left" colspan="1" rowspan="1">−0.3</td>
<td align="left" colspan="1" rowspan="1">−0.1</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sdf2l1</td>
<td align="left" colspan="1" rowspan="1">5.6</td>
<td align="left" colspan="1" rowspan="1">5.3</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.002</td>
<td align="left" colspan="1" rowspan="1">0.02</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lrg1</td>
<td align="left" colspan="1" rowspan="1">4.1</td>
<td align="left" colspan="1" rowspan="1">2.5</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.02</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>Fkbp5</bold>
</td>
<td align="left" colspan="1" rowspan="1">7.8</td>
<td align="left" colspan="1" rowspan="1">8.0</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">4.81E‐06</td>
<td align="left" colspan="1" rowspan="1">0.03</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dok3</td>
<td align="left" colspan="1" rowspan="1">5.2</td>
<td align="left" colspan="1" rowspan="1">4.9</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.5</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.03</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hspa5</td>
<td align="left" colspan="1" rowspan="1">10.7</td>
<td align="left" colspan="1" rowspan="1">10.8</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Manf</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">7.9</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.1</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hspa1a</td>
<td align="left" colspan="1" rowspan="1">6.8</td>
<td align="left" colspan="1" rowspan="1">6.0</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">0.4</td>
<td align="left" colspan="1" rowspan="1">0.2</td>
<td align="left" colspan="1" rowspan="1">0.03</td>
<td align="left" colspan="1" rowspan="1">0.05</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="cns12810-note-0003">
<p>Column titles from left to right: official gene symbol; PFC, prefrontal cortex; dorsal CPu, dorsal striatum; FC stress, fold change stress; FC Rim, fold change Rimonabant; FC WIN, fold change WIN55212.2; <italic>q</italic> value Stress, <italic>P</italic> adjust value Stress; <italic>q</italic> value Rim, <italic>P</italic> adjust value Rimonabant; <italic>q</italic> value WIN, <italic>P</italic> adjust value WIN55212.2.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
</sec>
<sec id="cns12810-sec-0025">
<label>4</label>
<title>DISCUSSION</title>
<p>Long‐term stress confers risk to develop psychiatric disorders and symptoms.<xref ref-type="ref" rid="cns12810-bib-0025">25</xref> In response to prolonged stress, glucocorticoid release has been shown to have deleterious effects on different brain regions and also is associated with the regression of synapses and dendritic spines.<xref ref-type="ref" rid="cns12810-bib-0026">26</xref> Remarkably, dysfunctions in corticostriatal connectivity have been involved in the pathophysiology of psychiatric disorders.<xref ref-type="ref" rid="cns12810-bib-0027">27</xref> Moreover, the G protein‐coupled CB<sub>1</sub> is extremely abundant and a key modulator of the corticostriatal pathways.<xref ref-type="ref" rid="cns12810-bib-0010">10</xref>
</p>
<sec id="cns12810-sec-0026">
<label>4.1</label>
<title>Effects of stress</title>
<p>After 2 weeks of daily psychosocial stress, animals showed loss of body weight in line with Iniguez et al.<xref ref-type="ref" rid="cns12810-bib-0028">28</xref> Our data revealed that chronic psychosocial stress exacerbates scratching activity.<xref ref-type="ref" rid="cns12810-bib-0029">29</xref> The endocannabinoid system has been described to have a direct effect on serotonergic neurotransmission which in turn, modulates several behaviors and physiological functions<xref ref-type="ref" rid="cns12810-bib-0016">16</xref> such as itch sensation.<xref ref-type="ref" rid="cns12810-bib-0030">30</xref> Moreover, the pronounced scratching phenotype reported here could also be attributable to the lower levels of AEA observed in the PFC.</p>
<p>In fact, pharmacological manipulation of the degrading enzymes leading to increased levels of AEA has shown a promising tool for reducing itch sensation.<xref ref-type="ref" rid="cns12810-bib-0031">31</xref> Additionally, mice with defective endocannabinoid signaling at CB<sub>1</sub> receptors displayed a pronounced scratching behavior (for review see Ref. <xref ref-type="ref" rid="cns12810-bib-0032">32</xref>).</p>
<p>Stress is well known to affect urinary bladder function and exacerbates signs of urinary bladder dysfunction. We demonstrated that socially defeated animals urinated more frequently probably caused by reduced bladder capacity as described.<xref ref-type="ref" rid="cns12810-bib-0033">33</xref>
</p>
<p>A decrease in motor activity is among the changes most commonly noted in subordinates and defeated animals.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> However, we found that social defeat animals traveled longer distances in the OF arena. These discrepancies could be attributable to methodological differences such as: (i) the use of mice rather than rats; (ii) housing conditions (five mice to a cage instead of just one); and (iii) the time at testing, as here the stress protocol and drug administration were performed during the active phase (after 8 <sc>pm</sc>) instead of the sleep phase. Finally, we measured an overexpression of <italic>Chrna6</italic> under stress. Studies of genetic linkage reported that the coding <italic>Chrna6</italic> region confers risk to develop neuropsychiatric disorders.<xref ref-type="ref" rid="cns12810-bib-0034">34</xref> Likewise, Kimbrel et al<xref ref-type="ref" rid="cns12810-bib-0035">35</xref> reported that two SNPs linked to CHRNA6 conferred risk for developing post‐traumatic stress disorder. Thus, the results described here point out a plausible contribution of Chrna6 to the long‐lasting effects observed in social defeat animals.</p>
</sec>
<sec id="cns12810-sec-0027">
<label>4.2</label>
<title>Effects of drug administration</title>
<p>Single administration of the agonist WIN reduced total distance traveled while acute treatment with the inverse agonist Rim slightly increased it when compared to controls an observation corroborated by Brzozka et al.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref>
</p>
<p>In the OF, mice treated with the inverse agonist Rim traveled longer distances in the center than the remaining groups, which support an anxiolytic effect mediated by the drug,<xref ref-type="ref" rid="cns12810-bib-0036">36</xref> even though CB<sub>1</sub> antagonism can also produce anxiogenic actions.<xref ref-type="ref" rid="cns12810-bib-0037">37</xref> Animals treated with Rim+WIN showed more frequent rearing behavior than WIN‐treated animals. Indeed, cannabis smoke exposure induced lower rearing activity, while the use of Rimonabant prevented the smoke‐induced decrease in rearing.<xref ref-type="ref" rid="cns12810-bib-0038">38</xref>
</p>
<p>Upon CB<sub>1</sub> activation by WIN, we observed an increase in the levels of both OEA and PEA, two mediators metabolically related to AEA. In line with our results, Bardou et al<xref ref-type="ref" rid="cns12810-bib-0039">39</xref> reported an increase in OEA and PEA contents after inhibiting the enzyme fatty acid amide hydrolase. Despite the fact that OEA and PEA levels often, but not always, change in a similar manner to those of AEA under physiological or pathological conditions, we did not observe here any similar changes in AEA levels following chronic psychosocial stress. This finding is compatible with the general concept that OEA and PEA are not eCBs in as much as they do not activate directly CB1 and CB2 receptors, but instead modulate noncannabinoid receptors, such as G protein‐coupled receptor 55 (GPR55), peroxisome proliferator‐activated receptor‐α (PPAR‐α), and transient receptor potential vanilloid type‐1 (TRPV1) channels. Recently, Musella et al reported that significant levels of PEA are present in the striatum, where this mediator enhances GABAergic neurotransmission via GPR55. Interestingly, PEA was previously reported to exhibit greater binding affinity for GPR55 than CB<sub>1</sub>, CB<sub>2</sub>, PPAR‐α, and TRPV1 (for review see Ref. <xref ref-type="ref" rid="cns12810-bib-0040">40</xref>). Thus, it is noteworthy to speculate that exposure to cannabinoid drugs, by altering PEA levels, modifies GPR55 receptor activity.</p>
<p>It is well known that the glucocorticoid receptor is regulated by several chaperones and cochaperones including the FKBP5 protein.<xref ref-type="ref" rid="cns12810-bib-0041">41</xref> In particular, we found that the administration of the CB<sub>1</sub> inverse agonist Rimonabant potentiated the expression of <italic>Fkbp5</italic> when compared to the remaining groups. This is in agreement with data showing that FKBP5 regulates glucocorticoid receptor sensitivity, increases its resistance, and decreases its efficiency at controlling the negative feedback in response to elevated levels of corticosterone,<xref ref-type="ref" rid="cns12810-bib-0042">42</xref> whereas Rimonabant can aggravate the hyperactivity of the HPA axis during stress.<xref ref-type="ref" rid="cns12810-bib-0043">43</xref> Several studies attest to the idea that FKBP5 is crucial for the development of stress‐related mental disorders <xref ref-type="ref" rid="cns12810-bib-0044">44</xref>, <xref ref-type="ref" rid="cns12810-bib-0045">45</xref>. However, it is currently unclear how the activation of the endocannabinoid system through the use of synthetic cannabinoid drugs may regulate either <italic>Fkbp5</italic> or glucocorticoid signaling as pointed out by Wang et al.<xref ref-type="ref" rid="cns12810-bib-0046">46</xref> In conclusion, our understanding of FKBP5 functions is still incomplete and thus, further work must address this question.</p>
</sec>
<sec id="cns12810-sec-0028">
<label>4.3</label>
<title>Effects of stress under drug influence</title>
<p>The inverse agonist Rimonabant in nonstress conditions antagonized the effects of WIN55212.2 on total distance travelled.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> Under experimentally induced psychosocial stress, mice treated with either WIN or Rim+WIN showed less total distance traveled than the vehicle group, while single Rimonabant administration antagonized the effects of WIN.<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> We also observed that stressed mice exposed to vehicle displayed an exacerbated total distance traveled when compared to their nonstressed counterparts. Against the present findings, Brzozka et al<xref ref-type="ref" rid="cns12810-bib-0003">3</xref> found that repeated exposure to social defeat paradigm reduced the total distance traveled in the OF. The differences reported here could be explained by the influence of the circadian rhythm and the housing conditions (5 mice per cage instead of just one). Indeed, mice are nocturnal animals mainly active during the dark period.<xref ref-type="ref" rid="cns12810-bib-0005">5</xref> Furthermore, the absence of social support (individual housing) amplifies the anxiety induced by psychosocial stress.<xref ref-type="ref" rid="cns12810-bib-0047">47</xref>
</p>
<p>It is widely accepted that upon HPA activation, the content of endocannabinoid lipid molecules varies according to the duration/type of stress stimuli and the brain structure. We found that social defeat animals exposed to vehicle showed similar 2‐AG levels than their controls in agreement with.<xref ref-type="ref" rid="cns12810-bib-0048">48</xref> In contrast, Gorzalka et al<xref ref-type="ref" rid="cns12810-bib-0049">49</xref> determined that after chronic stress, the endocannabinoid signaling was compromised because endocannabinoid levels were reduced in all limbic structures. Chronic restraint stress, for example, progressively increases 2‐AG content within distinct anatomical regions such as the medial PFC, limbic forebrain, amygdala, hippocampus, and hypothalamus.<xref ref-type="ref" rid="cns12810-bib-0050">50</xref> These differences could be explained by the influence of the circadian rhythm and also related to the stress protocol used. In fact, there is a strong evidence to suggest that in rodents circadian alterations occur in endocannabinoid brain levels,<xref ref-type="ref" rid="cns12810-bib-0051">51</xref> CB<sub>1</sub> expression,<xref ref-type="ref" rid="cns12810-bib-0052">52</xref> and the activity of enzymes controlling the metabolism of endocannabinoids.<xref ref-type="ref" rid="cns12810-bib-0051">51</xref> The administration of Rimonabant in controls as well as the pharmacological blockade of MAGL enzyme has been reported in a powerful increase of 2‐AG levels in the CNS.<xref ref-type="ref" rid="cns12810-bib-0053">53</xref> Here, such increase was also observed when both cannabinoids were administered but not when Rim was injected alone. Thus, the use of synthetic cannabinoids in this model warrants further investigation in order to elucidate the underlying mechanisms associated with the metabolism of 2‐AG.</p>
<p>Not surprisingly, we found that the cannabinoid agonist WIN and the inverse agonist Rim influenced the expressions of <italic>Chrna6</italic> and <italic>Slc6a4</italic> in opposite directions, while their coadministration tended to produce a net null effect under experimentally induced psychosocial stress. Nicotinic receptor containing α6 subunit (CHRNA6) is expressed in distinct brain regions important for addiction behaviors and also is identified to confer susceptibility to neuropsychiatric disorders.<xref ref-type="ref" rid="cns12810-bib-0034">34</xref> In line with this report, emerging data point out that the coding region for CHRNA6 confers vulnerability to drugs of abuse and their related behavioral phenotypes.<xref ref-type="ref" rid="cns12810-bib-0054">54</xref> Interestingly, the present investigation is the first to demonstrate that simultaneous exposure to distinct environmental factors such as chronic stress and acute cannabinoid drug administration can regulate the expression of the <italic>Chrna6</italic> gene which in turn and could be crucial for the development of cannabis addiction and psychosis. Long‐term exposure to stress constitutes a key environmental risk component for developing stress‐related disorders in susceptible individuals. The underlying mechanisms disrupted in these disorders are serotonergic<xref ref-type="ref" rid="cns12810-bib-0055">55</xref> and endocannabinoid<xref ref-type="ref" rid="cns12810-bib-0056">56</xref> dependent. Particularly, serotonin release inhibition is attributable to the lack of CB<sub>1</sub> receptors which in turn, promotes higher concentration of this neurotransmitter in the synaptic cleft.<xref ref-type="ref" rid="cns12810-bib-0057">57</xref> Then, we can speculate that CB<sub>1</sub> blockage by the administration of Rim could counteract the excessive serotonin neurotransmitter by increasing the expression of the serotonin transporter protein (<italic>Slc6a4</italic>).<xref ref-type="ref" rid="cns12810-bib-0058">58</xref> Furthermore, SLC6A4 single nucleotide polymorphisms have been associated with stress‐related psychiatric disorders,<xref ref-type="ref" rid="cns12810-bib-0059">59</xref> which are consistent with our findings.</p>
</sec>
</sec>
<sec id="cns12810-sec-0029">
<label>5</label>
<title>CONCLUSIONS</title>
<p>In summary, the data described here highlight the effects of long‐term exposure to stress on mouse corticostriatal circuitries following acute challenge with distinct cannabinoid drugs (For further details see Figure <xref ref-type="supplementary-material" rid="cns12810-sup-0002">S2</xref>). Particularly, we found that psychological stress played a role in the exacerbation of micturition frequency, anxiety‐related behavior,<xref ref-type="ref" rid="cns12810-bib-0058">58</xref> and scratching phenotype,<xref ref-type="ref" rid="cns12810-bib-0029">29</xref> while the use of synthetic cannabinoids drugs interfered with locomotor activity, rearing, and anxiety‐like behavior.<xref ref-type="ref" rid="cns12810-bib-0038">38</xref> The glucocorticoid receptor is regulated by several chaperones and cochaperones including the FKBP5 protein<xref ref-type="ref" rid="cns12810-bib-0041">41</xref> but also is influenced by endocannabinoid system.<xref ref-type="ref" rid="cns12810-bib-0017">17</xref> Additionally, we demonstrated that psychosocially stressed animals displayed changes in the serotonergic system upon acute exposure to synthetic cannabinoid drugs.<xref ref-type="ref" rid="cns12810-bib-0055">55</xref> The coding region for CHRNA6 confers vulnerability to drugs of abuse and their related behavioral phenotypes,<xref ref-type="ref" rid="cns12810-bib-0054">54</xref> which in turn, could be crucial for the development of cannabis addiction and psychosis. Our findings in both PFC and dorsal CPu need to be corroborated by further studies if we want to understand the role of CB<sub>1</sub> and endocannabinoids and related mediators in corticostriatal signaling under psychosocial stress.</p>
</sec>
<sec id="cns12810-sec-0031" sec-type="COI-statement">
<title>CONFLICTS OF INTEREST</title>
<p>The author reports no potential conflict of interests.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="cns12810-sup-0001">
<caption>
<p> </p>
</caption>
<media xlink:href="CNS-24-528-s001.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="cns12810-sup-0002">
<caption>
<p> </p>
</caption>
<media xlink:href="CNS-24-528-s002.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="cns12810-sup-0003">
<caption>
<p> </p>
</caption>
<media xlink:href="CNS-24-528-s003.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="cns12810-sup-0004">
<caption>
<p> </p>
</caption>
<media xlink:href="CNS-24-528-s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="cns12810-sup-0005">
<caption>
<p> </p>
</caption>
<media xlink:href="CNS-24-528-s005.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="cns12810-sec-0030">
<title>ACKNOWLEDGMENTS</title>
<p>We thank Prof. Lutz from University Medical Center of the Johannes Gutenberg University (Germany) for supplying the CB<sub>1</sub> riboprobe. The authors would like to thank Prof. Colomina, Dr. Yang, and Mr. Ludewig for excellent technical support. Dr. Gil was supported by Juan de la Cierva postdoctoral fellowship of MINECO. Dr. Tomas‐Roig was supported by Deutsche Forschungsgemeinschaft fellowship (Grant TO 977/1‐1). The work was supported by DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) and the German‐Research‐Foundation (DFG) grant CNMPB C1‐6 to Prof. Havemann‐Reinecke.</p>
</ack>
<ref-list content-type="cited-references" id="cns12810-bibl-0001">
<title>REFERENCES</title>
<ref id="cns12810-bib-0001">
<label>1</label>
<mixed-citation id="cns12810-cit-0001" publication-type="journal">
<string-name>
<surname>van Os</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kenis</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rutten</surname>
<given-names>BPF</given-names>
</string-name>. <article-title>The environment and schizophrenia</article-title>. <source xml:lang="en"/>Nature. <year>2010</year>;<volume>468</volume>:<fpage>203</fpage>‐<lpage>212</lpage>.<pub-id pub-id-type="pmid">21068828</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0002">
<label>2</label>
<mixed-citation id="cns12810-cit-0002" publication-type="journal">
<string-name>
<surname>Fornito</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Harrison</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Goodby</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis</article-title>. <source xml:lang="en"/>JAMA Psychiatry [Internet]. <year>2013</year>;<volume>70</volume>:<fpage>1143</fpage>‐<lpage>1151</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0003">
<label>3</label>
<mixed-citation id="cns12810-cit-0003" publication-type="journal">
<string-name>
<surname>Brzozka</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Falkai</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Havemann‐Reinecke</surname>
<given-names>U</given-names>
</string-name>. <article-title>Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice</article-title>. <source xml:lang="en"/>Behav Brain Res. <year>2011</year>;<volume>218</volume>:<fpage>280</fpage>‐<lpage>287</lpage>.<pub-id pub-id-type="pmid">21070814</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0004">
<label>4</label>
<mixed-citation id="cns12810-cit-0004" publication-type="journal">
<string-name>
<surname>Sapolsky</surname>
<given-names>R</given-names>
</string-name>. <article-title>Taming stress</article-title>. <source xml:lang="en"/>Sci Am. <year>2003</year>;<volume>289</volume>:<fpage>86</fpage>‐<lpage>95</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0005">
<label>5</label>
<mixed-citation id="cns12810-cit-0005" publication-type="journal">
<string-name>
<surname>de Kloet</surname>
<given-names>ER</given-names>
</string-name>. <article-title>Stress in the brain</article-title>. <source xml:lang="en"/>Eur J Pharmacol. <year>2000</year>;<volume>405</volume>:<fpage>187</fpage>‐<lpage>198</lpage>.<pub-id pub-id-type="pmid">11033326</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0006">
<label>6</label>
<mixed-citation id="cns12810-cit-0006" publication-type="journal">
<string-name>
<surname>Duval</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Javanbakht</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Liberzon</surname>
<given-names>I</given-names>
</string-name>. <article-title>Neural circuits in anxiety and stress disorders: a focused review</article-title>. <source xml:lang="en"/>Ther Clin Risk Manag. <year>2015</year>;<volume>11</volume>:<fpage>115</fpage>‐<lpage>126</lpage>.<pub-id pub-id-type="pmid">25670901</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0007">
<label>7</label>
<mixed-citation id="cns12810-cit-0007" publication-type="journal">
<string-name>
<surname>Blair</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Geraci</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Otero</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Atypical modulation of medial prefrontal cortex to self‐referential comments in generalized social phobia</article-title>. <source xml:lang="en"/>Psychiatry Res. <year>2011</year>;<volume>193</volume>:<fpage>38</fpage>‐<lpage>45</lpage>.<pub-id pub-id-type="pmid">21601433</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0008">
<label>8</label>
<mixed-citation id="cns12810-cit-0008" publication-type="journal">
<string-name>
<surname>Sripada</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Angstadt</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liberzon</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>McCabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Phan</surname>
<given-names>KL</given-names>
</string-name>. <article-title>Aberrant reward center response to partner reputation during a social exchange game in generalized social phobia</article-title>. <source xml:lang="en"/>Depress Anxiety. <year>2013</year>;<volume>30</volume>:<fpage>353</fpage>‐<lpage>361</lpage>.<pub-id pub-id-type="pmid">23576237</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0009">
<label>9</label>
<mixed-citation id="cns12810-cit-0009" publication-type="journal">
<string-name>
<surname>Boychuk</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Zsombok</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tasker</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>BN</given-names>
</string-name>. <article-title>Rapid glucocorticoid‐induced activation of TRP and CB1 receptors causes biphasic modulation of glutamate release in gastric‐related hypothalamic preautonomic neurons</article-title>. <source xml:lang="en"/>Front Neurosci. <year>2013</year>;<volume>7</volume>:<fpage>3</fpage>.<pub-id pub-id-type="pmid">23386808</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0010">
<label>10</label>
<mixed-citation id="cns12810-cit-0010" publication-type="journal">
<string-name>
<surname>Herkenham</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lynn</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Melvin</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>de Costa</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Rice</surname>
<given-names>KC</given-names>
</string-name>. <article-title>Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study</article-title>. <source xml:lang="en"/>J Neurosci [Internet]. <year>1991</year>;<volume>11</volume>:<fpage>563</fpage>‐<lpage>583</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0011">
<label>11</label>
<mixed-citation id="cns12810-cit-0011" publication-type="book">
<string-name>
<surname>Lovinger</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Costa</surname>
<given-names>RM</given-names>
</string-name>. <source xml:lang="en"/>Handbook of Basal Ganglia Structure and Function. <person-group person-group-type="editor"><name><surname>Steiner</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Tseng</surname><given-names>K</given-names></name></person-group>, eds. <publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name>; <year>2010</year>:<fpage>693</fpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0012">
<label>12</label>
<mixed-citation id="cns12810-cit-0012" publication-type="journal">
<string-name>
<surname>Devane</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Hanus</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Breuer</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Isolation and structure of a brain constituent that binds to the cannabinoid receptor</article-title>. <source xml:lang="en"/>Science. <year>1992</year>;<volume>258</volume>:<fpage>1946</fpage>‐<lpage>1949</lpage>.<pub-id pub-id-type="pmid">1470919</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0013">
<label>13</label>
<mixed-citation id="cns12810-cit-0013" publication-type="journal">
<string-name>
<surname>Sugiura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sukagawa</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>2‐arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun [Internet]. <year>1995</year>;<volume>215</volume>:<fpage>89</fpage>‐<lpage>97</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0014">
<label>14</label>
<mixed-citation id="cns12810-cit-0014" publication-type="journal">
<string-name>
<surname>Basavarajappa</surname>
<given-names>BS</given-names>
</string-name>. <article-title>Critical enzymes involved in endocannabinoid metabolism</article-title>. <source xml:lang="en"/>Protein Pept Lett. <year>2007</year>;<volume>14</volume>:<fpage>237</fpage>‐<lpage>246</lpage>.<pub-id pub-id-type="pmid">17346227</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0015">
<label>15</label>
<mixed-citation id="cns12810-cit-0015" publication-type="journal">
<string-name>
<surname>Di Marzo</surname>
<given-names>V</given-names>
</string-name>. <article-title>Endocannabinoids: synthesis and degradation</article-title>. <source xml:lang="en"/>Rev Physiol Biochem Pharmacol. <year>2008</year>;<volume>160</volume>:<fpage>1</fpage>‐<lpage>24</lpage>.<pub-id pub-id-type="pmid">18481028</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0016">
<label>16</label>
<mixed-citation id="cns12810-cit-0016" publication-type="journal">
<string-name>
<surname>Lazary</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Juhasz</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hunyady</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bagdy</surname>
<given-names>G</given-names>
</string-name>. <article-title>Personalized medicine can pave the way for the safe use of CB 1 receptor antagonists</article-title>. <source xml:lang="en"/>Trends Pharmacol Sci. <year>2011</year>;<volume>32</volume>:<fpage>270</fpage>‐<lpage>280</lpage>.<pub-id pub-id-type="pmid">21497918</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0017">
<label>17</label>
<mixed-citation id="cns12810-cit-0017" publication-type="journal">
<string-name>
<surname>Tasker</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Di</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Malcher‐Lopes</surname>
<given-names>R</given-names>
</string-name>. <article-title>Minireview: rapid glucocorticoid signaling via membrane‐associated receptors</article-title>. <source xml:lang="en"/>Endocrinology. <year>2006</year>;<volume>147</volume>:<fpage>5549</fpage>‐<lpage>5556</lpage>.<pub-id pub-id-type="pmid">16946006</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0018">
<label>18</label>
<mixed-citation id="cns12810-cit-0018" publication-type="journal">
<string-name>
<surname>Golub</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Germann</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Lloyd</surname>
<given-names>KC</given-names>
</string-name>. <article-title>Behavioral characteristics of a nervous system‐specific erbB4 knock‐out mouse</article-title>. <source xml:lang="en"/>Behav Brain Res. <year>2004</year>;<volume>153</volume>:<fpage>159</fpage>‐<lpage>170</lpage>.<pub-id pub-id-type="pmid">15219717</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0019">
<label>19</label>
<mixed-citation id="cns12810-cit-0019" publication-type="journal">
<string-name>
<surname>Matias</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Petrosino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Racioppi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Capasso</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Izzo</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Di Marzo</surname>
<given-names>V</given-names>
</string-name>. <article-title>Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets</article-title>. <source xml:lang="en"/>Mol Cell Endocrinol. <year>2008</year>;<volume>286</volume>(<issue>1–2 suppl 1</issue>):<fpage>S66</fpage>‐<lpage>S78</lpage>.<pub-id pub-id-type="pmid">18343566</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0020">
<label>20</label>
<mixed-citation id="cns12810-cit-0020" publication-type="journal">
<string-name>
<surname>Bisogno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Martire</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Petrosino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Popoli</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Di Marzo</surname>
<given-names>V</given-names>
</string-name>. <article-title>Symptom‐related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease</article-title>. <source xml:lang="en"/>Neurochem Int. <year>2008</year>;<volume>52</volume>:<fpage>307</fpage>‐<lpage>313</lpage>.<pub-id pub-id-type="pmid">17664017</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0021">
<label>21</label>
<mixed-citation id="cns12810-cit-0021" publication-type="journal">
<string-name>
<surname>Pruitt</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Hiatt</surname>
<given-names>SM</given-names>
</string-name>, et al. <article-title>RefSeq: an update on mammalian reference sequences</article-title>. <source xml:lang="en"/>Nucleic Acids Res [Internet]. <year>2014</year>;<volume>42</volume>:<fpage>D756</fpage>‐<lpage>D763</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0022">
<label>22</label>
<mixed-citation id="cns12810-cit-0022" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Durbin</surname>
<given-names>R</given-names>
</string-name>. <article-title>Fast and accurate short read alignment with Burrows‐Wheeler transform</article-title>. <source xml:lang="en"/>Bioinformatics. <year>2009</year>;<volume>25</volume>:<fpage>1754</fpage>‐<lpage>1760</lpage>.<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0023">
<label>23</label>
<mixed-citation id="cns12810-cit-0023" publication-type="journal">
<string-name>
<surname>Anders</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huber</surname>
<given-names>W</given-names>
</string-name>. <article-title>Differential expression analysis for sequence count data</article-title>. <source xml:lang="en"/>Genome Biol. <year>2010</year>;<volume>11</volume>:<fpage>R106</fpage>.<pub-id pub-id-type="pmid">20979621</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0024">
<label>24</label>
<mixed-citation id="cns12810-cit-0024" publication-type="journal">
<string-name>
<surname>Benjamini</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hochberg</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source xml:lang="en"/>J R Stat Soc Ser B [Internet]. <year>1995</year>;<volume>57</volume>:<fpage>289</fpage>‐<lpage>300</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0025">
<label>25</label>
<mixed-citation id="cns12810-cit-0025" publication-type="journal">
<string-name>
<surname>Holtzman</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Trotman</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Goulding</surname>
<given-names>SM</given-names>
</string-name>, et al. <article-title>Stress and neurodevelopmental processes in the emergence of psychosis</article-title>. <source xml:lang="en"/>Neuroscience. <year>2013</year>;<volume>249</volume>:<fpage>172</fpage>‐<lpage>191</lpage>.<pub-id pub-id-type="pmid">23298853</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0026">
<label>26</label>
<mixed-citation id="cns12810-cit-0026" publication-type="journal">
<string-name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</string-name>. <article-title>The ever‐changing brain: cellular and molecular mechanisms for the effects of stressful experiences</article-title>. <source xml:lang="en"/>Dev Neurobiol. <year>2012</year>;<volume>72</volume>:<fpage>878</fpage>‐<lpage>890</lpage>.<pub-id pub-id-type="pmid">21898852</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0027">
<label>27</label>
<mixed-citation id="cns12810-cit-0027" publication-type="journal">
<string-name>
<surname>Shepherd</surname>
<given-names>GMG</given-names>
</string-name>. <article-title>Corticostriatal connectivity and its role in disease</article-title>. <source xml:lang="en"/>Nat Rev Neurosci [Internet]. <year>2013</year>;<volume>14</volume>:<fpage>278</fpage>‐<lpage>291</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0028">
<label>28</label>
<mixed-citation id="cns12810-cit-0028" publication-type="journal">
<string-name>
<surname>Iñiguez</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Riggs</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Nieto</surname>
<given-names>SJ</given-names>
</string-name>, et al. <article-title>Social defeat stress induces a depression‐like phenotype in adolescent male c57BL/6 mice</article-title>. <source xml:lang="en"/>Stress [Internet]. <year>2014</year>;<volume>17</volume>:<fpage>247</fpage>‐<lpage>255</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0029">
<label>29</label>
<mixed-citation id="cns12810-cit-0029" publication-type="journal">
<string-name>
<surname>Zhao</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hiramoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Asano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kubo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sudo</surname>
<given-names>N</given-names>
</string-name>. <article-title>Chronic psychological stress exaggerates the compound 48/80‐induced scratching behavior of mice</article-title>. <source xml:lang="en"/>Pharmacol Biochem Behav. <year>2013</year> Apr;<volume>105</volume>:<fpage>173</fpage>‐<lpage>176</lpage>.<pub-id pub-id-type="pmid">23474370</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0030">
<label>30</label>
<mixed-citation id="cns12810-cit-0030" publication-type="journal">
<string-name>
<surname>Weisshaar</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ziethen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Röhl</surname>
<given-names>FW</given-names>
</string-name>, <string-name>
<surname>Gollnick</surname>
<given-names>H</given-names>
</string-name>. <article-title>The antipruritic effect of a 5‐HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion—an experimental study</article-title>. <source xml:lang="en"/>Exp Dermatol [Internet]. <year>1999</year>;<volume>8</volume>:<fpage>254</fpage>‐<lpage>260</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0031">
<label>31</label>
<mixed-citation id="cns12810-cit-0031" publication-type="journal">
<string-name>
<surname>Tosun</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Gunduz</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ulugol</surname>
<given-names>A</given-names>
</string-name>. <article-title>Attenuation of serotonin‐induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase</article-title>. <source xml:lang="en"/>J Neural Transm. <year>2014</year>;<volume>122</volume>:<fpage>363</fpage>‐<lpage>367</lpage>.<pub-id pub-id-type="pmid">24915981</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0032">
<label>32</label>
<mixed-citation id="cns12810-cit-0032" publication-type="journal">
<string-name>
<surname>Caterina</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation</article-title>. <source xml:lang="en"/>ACS Chem Neurosci. <year>2014</year>;<volume>5</volume>:<fpage>1107</fpage>‐<lpage>1116</lpage>.<pub-id pub-id-type="pmid">24915599</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0033">
<label>33</label>
<mixed-citation id="cns12810-cit-0033" publication-type="journal">
<string-name>
<surname>Mingin</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Erickson</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Vizzard</surname>
<given-names>M</given-names>
</string-name>. <article-title>Social stress induces changes in urinary bladder function, bladder NGF content, and generalized bladder inflammation in mice</article-title>. <source xml:lang="en"/>Am J Physiol Regul Integr Comp Physiol. <year>2014</year>;<volume>307</volume>:<fpage>R893</fpage>‐<lpage>R900</lpage>.<pub-id pub-id-type="pmid">25100077</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0034">
<label>34</label>
<mixed-citation id="cns12810-cit-0034" publication-type="journal">
<string-name>
<surname>Tabarés‐Seisdedos</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</string-name>. <article-title>Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer</article-title>. <source xml:lang="en"/>Mol Psychiatry [Internet]. <year>2009</year>;<volume>14</volume>:<fpage>563</fpage>‐<lpage>589</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0035">
<label>35</label>
<mixed-citation id="cns12810-cit-0035" publication-type="journal">
<string-name>
<surname>Kimbrel</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Garrett</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Dennis</surname>
<given-names>MF</given-names>
</string-name>, et al. <article-title>Effect of genetic variation in the nicotinic receptor genes on risk for posttraumatic stress disorder</article-title>. <source xml:lang="en"/>Psychiatry Res. <year>2015</year>;<volume>229</volume>:<fpage>326</fpage>‐<lpage>331</lpage>.<pub-id pub-id-type="pmid">26184988</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0036">
<label>36</label>
<mixed-citation id="cns12810-cit-0036" publication-type="journal">
<string-name>
<surname>Lafenêtre</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chaouloff</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Marsicano</surname>
<given-names>G</given-names>
</string-name>. <article-title>The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction</article-title>. <source xml:lang="en"/>Pharmacol Res. <year>2007</year>;<volume>56</volume>:<fpage>367</fpage>‐<lpage>381</lpage>.<pub-id pub-id-type="pmid">17951068</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0037">
<label>37</label>
<mixed-citation id="cns12810-cit-0037" publication-type="journal">
<string-name>
<surname>Komaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Abdollahzadeh</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sarihi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shahidi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Salehi</surname>
<given-names>I</given-names>
</string-name>. <article-title>Interaction between antagonist of cannabinoid receptor and antagonist of adrenergic receptor on anxiety in male rat</article-title>. <source xml:lang="en"/>Basic Clin Neurosci. <year>2014</year>;<volume>5</volume>:<fpage>218</fpage>‐<lpage>224</lpage>.<pub-id pub-id-type="pmid">25337383</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0038">
<label>38</label>
<mixed-citation id="cns12810-cit-0038" publication-type="journal">
<string-name>
<surname>Bruijnzeel</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Guzhva</surname>
<given-names>LV</given-names>
</string-name>, et al. <article-title>Behavioral characterization of the effects of cannabis smoke and anandamide in rats</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2016</year>;<volume>11</volume>:<fpage>e0153327</fpage>.<pub-id pub-id-type="pmid">27065006</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0039">
<label>39</label>
<mixed-citation id="cns12810-cit-0039" publication-type="journal">
<string-name>
<surname>Bardou</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>DiPatrizio</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Brothers</surname>
<given-names>HM</given-names>
</string-name>, et al. <article-title>Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging</article-title>. <source xml:lang="en"/>Health (Irvine Calif) [Internet]. <year>2012</year>;<volume>4</volume>:<fpage>679</fpage>‐<lpage>684</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0040">
<label>40</label>
<mixed-citation id="cns12810-cit-0040" publication-type="journal">
<string-name>
<surname>Musella</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fresegna</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rizzo</surname>
<given-names>FR</given-names>
</string-name>, et al. <article-title>A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum</article-title>. <source xml:lang="en"/>Sci Rep. <year>2017</year>;<volume>7</volume>:<fpage>7363</fpage>.<pub-id pub-id-type="pmid">28779174</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0041">
<label>41</label>
<mixed-citation id="cns12810-cit-0041" publication-type="journal">
<string-name>
<surname>Wochnik</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Rüegg</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Abel</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Holsboer</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Rein</surname>
<given-names>T</given-names>
</string-name>. <article-title>FK506‐binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2005</year>;<volume>280</volume>:<fpage>4609</fpage>‐<lpage>4616</lpage>.<pub-id pub-id-type="pmid">15591061</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0042">
<label>42</label>
<mixed-citation id="cns12810-cit-0042" publication-type="journal">
<string-name>
<surname>Binder</surname>
<given-names>EB</given-names>
</string-name>. <article-title>The role of FKBP5, a co‐chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders</article-title>. <source xml:lang="en"/>Psychoneuroendocrinology. <year>2009</year>;<volume>34</volume>(<issue>suppl 1</issue>):<fpage>S186</fpage>‐<lpage>S195</lpage>.<pub-id pub-id-type="pmid">19560279</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0043">
<label>43</label>
<mixed-citation id="cns12810-cit-0043" publication-type="journal">
<string-name>
<surname>Blasio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Iemolo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sabino</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala</article-title>. <source xml:lang="en"/>Neuropsychopharmacology [Internet]. <year>2013</year>;<volume>38</volume>:<fpage>2498</fpage>‐<lpage>2507</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0044">
<label>44</label>
<mixed-citation id="cns12810-cit-0044" publication-type="journal">
<string-name>
<surname>Xie</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kranzler</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Poling</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Interaction of FKBP5 with childhood adversity on risk for post‐traumatic stress disorder</article-title>. <source xml:lang="en"/>Neuropsychopharmacology. <year>2010</year>;<volume>35</volume>:<fpage>1684</fpage>‐<lpage>1692</lpage>.<pub-id pub-id-type="pmid">20393453</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0045">
<label>45</label>
<mixed-citation id="cns12810-cit-0045" publication-type="journal">
<string-name>
<surname>Zimmermann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Brückl</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nocon</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10 ‐year prospective community study</article-title>. <source xml:lang="en"/>Am J Psychiatry. <year>2011</year>;<volume>168</volume>:<fpage>1107</fpage>‐<lpage>1116</lpage>.<pub-id pub-id-type="pmid">21865530</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0046">
<label>46</label>
<mixed-citation id="cns12810-cit-0046" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gorzalka</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Hillard</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Alger</surname>
<given-names>BE</given-names>
</string-name>. <article-title>Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation</article-title>. <source xml:lang="en"/>J Psychopharmacol. <year>2012</year>;<volume>26</volume>:<fpage>56</fpage>‐<lpage>70</lpage>.<pub-id pub-id-type="pmid">21890595</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0047">
<label>47</label>
<mixed-citation id="cns12810-cit-0047" publication-type="journal">
<string-name>
<surname>Adamcio</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Havemann‐Reinecke</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Ehrenreich</surname>
<given-names>H</given-names>
</string-name>. <article-title>Chronic psychosocial stress in the absence of social support induces pathological pre‐pulse inhibition in mice</article-title>. <source xml:lang="en"/>Behav Brain Res. <year>2009</year>;<volume>204</volume>:<fpage>246</fpage>‐<lpage>249</lpage>.<pub-id pub-id-type="pmid">19482043</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0048">
<label>48</label>
<mixed-citation id="cns12810-cit-0048" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress</article-title>. <source xml:lang="en"/>Neuropsychopharmacology. <year>2010</year>;<volume>35</volume>:<fpage>2249</fpage>‐<lpage>2261</lpage>.<pub-id pub-id-type="pmid">20664582</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0049">
<label>49</label>
<mixed-citation id="cns12810-cit-0049" publication-type="journal">
<string-name>
<surname>Gorzalka</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Hillard</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Regulation of endocannabinoid signaling by stress: implications for stress‐related affective disorders</article-title>. <source xml:lang="en"/>Neurosci Biobehav Rev. <year>2008</year>;<volume>32</volume>:<fpage>1152</fpage>‐<lpage>1160</lpage>.<pub-id pub-id-type="pmid">18433869</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0050">
<label>50</label>
<mixed-citation id="cns12810-cit-0050" publication-type="journal">
<string-name>
<surname>Patel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kingsley</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Mackie</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Marnett</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Winder</surname>
<given-names>DG</given-names>
</string-name>. <article-title>Repeated homotypic stress elevates 2‐arachidonoylglycerol levels and enhances short‐term endocannabinoid signaling at inhibitory synapses in basolateral amygdala</article-title>. <source xml:lang="en"/>Neuropsychopharmacology. <year>2009</year>;<volume>34</volume>:<fpage>2699</fpage>‐<lpage>2709</lpage>.<pub-id pub-id-type="pmid">19675536</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0051">
<label>51</label>
<mixed-citation id="cns12810-cit-0051" publication-type="journal">
<string-name>
<surname>Valenti</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Viganò</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Casico</surname>
<given-names>MG</given-names>
</string-name>, et al. <article-title>Differential diurnal variations of anandamide and 2‐arachidonoyl‐glycerol levels in rat brain</article-title>. <source xml:lang="en"/>Cell Mol Life Sci. <year>2004</year>;<volume>61</volume>:<fpage>945</fpage>‐<lpage>950</lpage>.<pub-id pub-id-type="pmid">15095014</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0052">
<label>52</label>
<mixed-citation id="cns12810-cit-0052" publication-type="journal">
<string-name>
<surname>Rueda‐Orozco</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Soria‐Gomez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Montes‐Rodriguez</surname>
<given-names>CJ</given-names>
</string-name>, et al. <article-title>A potential function of endocannabinoids in the selection of a navigation strategy by rats</article-title>. <source xml:lang="en"/>Psychopharmacology. <year>2008</year>;<volume>198</volume>:<fpage>565</fpage>‐<lpage>576</lpage>.<pub-id pub-id-type="pmid">17805517</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0053">
<label>53</label>
<mixed-citation id="cns12810-cit-0053" publication-type="journal">
<string-name>
<surname>Chanda</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mark</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</article-title>. <source xml:lang="en"/>Mol Pharmacol [Internet]. <year>2010</year>;<volume>78</volume>:<fpage>996</fpage>‐<lpage>1003</lpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0054">
<label>54</label>
<mixed-citation id="cns12810-cit-0054" publication-type="journal">
<string-name>
<surname>Sadler</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Haller</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Agrawal</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Variants near CHRNB3‐CHRNA6 are associated with DSM‐5 cocaine use disorder: evidence for pleiotropy</article-title>. <source xml:lang="en"/>Sci Rep [Internet]. <year>2014</year>;<volume>4</volume>:<fpage>4497</fpage>.</mixed-citation>
</ref>
<ref id="cns12810-bib-0055">
<label>55</label>
<mixed-citation id="cns12810-cit-0055" publication-type="journal">
<string-name>
<surname>Inoue</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tsuchiya</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>T</given-names>
</string-name>. <article-title>Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain</article-title>. <source xml:lang="en"/>Pharmacol Biochem Behav. <year>1994</year>;<volume>49</volume>:<fpage>911</fpage>‐<lpage>920</lpage>.<pub-id pub-id-type="pmid">7886107</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0056">
<label>56</label>
<mixed-citation id="cns12810-cit-0056" publication-type="journal">
<string-name>
<surname>Burokas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Martín‐García</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gutiérrez‐Cuesta</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Relationships between serotonergic and cannabinoid system in depressive‐like behavior: a PET study with [<sup>11</sup>C]‐DASB</article-title>. <source xml:lang="en"/>J Neurochem. <year>2014</year>;<volume>130</volume>:<fpage>126</fpage>‐<lpage>135</lpage>.<pub-id pub-id-type="pmid">24646401</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0057">
<label>57</label>
<mixed-citation id="cns12810-cit-0057" publication-type="journal">
<string-name>
<surname>Rudnick</surname>
<given-names>G</given-names>
</string-name>. <article-title>Serotonin transporters—structure and function</article-title>. <source xml:lang="en"/>J Membr Biol. <year>2006</year>;<volume>213</volume>:<fpage>101</fpage>‐<lpage>110</lpage>.<pub-id pub-id-type="pmid">17417703</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0058">
<label>58</label>
<mixed-citation id="cns12810-cit-0058" publication-type="journal">
<string-name>
<surname>Karg</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Burmeister</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shedden</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sen</surname>
<given-names>S</given-names>
</string-name>. <article-title>The serotonin transporter promoter variant (5‐HTTLPR), stress, and depression meta‐analysis revisited: evidence of genetic moderation</article-title>. <source xml:lang="en"/>Arch Gen Psychiatry. <year>2011</year>;<volume>68</volume>:<fpage>444</fpage>‐<lpage>454</lpage>.<pub-id pub-id-type="pmid">21199959</pub-id></mixed-citation>
</ref>
<ref id="cns12810-bib-0059">
<label>59</label>
<mixed-citation id="cns12810-cit-0059" publication-type="journal">
<string-name>
<surname>Smith</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kun</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>The effects of acute and chronic psychological stress on bladder function in a rodent model</article-title>. <source xml:lang="en"/>Urology. <year>2011</year>;<volume>78</volume>:<fpage>967</fpage>.e1‐7.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>